Harding Loevner Global Equity Inst
HLMVX
NASDAQ32.79
USD
+0.21
- -
Harding Loevner Global Equity Inst
HLMVX
(NASDAQ)
Recent
price
32.79
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Harding Loevner Global Equity Portfolio (HLMVX) is a mutual fund managed by Harding Loevner LP, focusing on long-term capital appreciation through investments in high-quality global equities. The portfolio invests primarily in common stocks of established companies domiciled anywhere in the world, with emphasis on those exhibiting sustainable high returns on capital, strong balance sheets, and capable management; it typically holds 40 to 60 securities across diverse sectors including consumer staples, information technology, financials, health care, and industrials, while maintaining a market-cap weighted benchmark against the MSCI All Country World Index (ACWI). Harding Loevner LP, founded in 1989 and headquartered in Long Island City, New York, serves institutional and individual investors seeking global equity exposure with a quality-growth orientation. The fund offers share classes including Institutional (HLMVX), Advisor (HLMAD), and Research (HLMRX), catering to different investor types such as retirement plans, financial advisors, and high-net-worth individuals; it employs a fundamental, bottom-up research process emphasizing business quality over market timing. Geographically, the portfolio allocates across developed and emerging markets, with significant exposure to the United States, Europe, Japan, and select emerging economies like India and China. In recent developments, Harding Loevner LP announced enhancements to its emerging markets strategies in 2024, integrating advanced ESG analytics into portfolio construction; the firm also expanded its research team with key hires from leading global asset managers to bolster coverage in technology and healthcare sectors. Additionally, as of late 2025, the Global Equity Portfolio benefited from strategic positioning amid U.S. market leadership under President Trump's reelection, with overweight positions in resilient quality names navigating geopolitical shifts and interest rate dynamics.